Orally administrable Pharmaceutical composition comprising a modifier of intestinal motility, an agent that prevents the gas holdup and Digestive Enzymes； Preparation Process and their use for the Prevention or treatment of intestinal Disorders and irritable bowel syndrome.
BERNARDO ESCUDERO, ROBERTO,SAVOIR VILBOUEF, JOHN CLAUDE
申请号：
CL2013001331
公开号：
CL2013001331A1
申请日:
2013.05.14
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The invention relates to a pharmaceutical formulation or composition intended to be administered orally in the form of a tablet, a coated tablet or a capsule, for the prevention or treatment of intestinal disorders, such as irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, digestive enzymes, a binding agent, a diluent, an adsorbent agent, a disintegrating agent, a lubricant and a glidant, effective for normalising colon transit, for providing an analgesic activity, for providing an antispasmodic activity and for reducing symptoms related to intestinal gas, such as distention, abdominal pain and flatulence.COMPOSICION FARMACEUTICA ADMINISTRABLE ORALMENTE QUE COMPRENDE UN MODIFICADOR DE LA MOTILIDAD INTESTINAL, UN AGENTE QUE PREVIENE LA RETENCION DE GAS Y ENZIMAS DIGESTIVAS； PROCESO DE PREPARACION Y SU USO PARA LA PREVENCION O TRATAMIENTO DE TRASTORNOS INTESTINALES Y EL SINDROME DE COLON IRRITABLE.
